| |
| |
|
| Insider
Information: |
Urist Marshall |
| Relationship: |
EVP, Research & Invest... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
46,667 |
|
|
Indirect Shares
|
19,020 |
|
|
| Direct
Value |
$1,319,743 |
|
|
|
Indirect Value
|
$537,886 |
|
|
| Total
Shares |
65,687 |
|
|
| Total
Value |
$1,857,628 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Royalty Pharma Plc |
RPRX |
EVP, Research & Invest... |
2023-02-22 |
46,667 |
2023-02-22 |
19,020 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RPRX |
Royalty Pharma Plc |
EVP, Research & Investments |
• – – |
2023-02-22 |
4 |
S |
$37.30 |
$870,239 |
D/D |
(23,333) |
46,667 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Research & Investments |
• – – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
70,000 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
EVP, Research & Investments |
• – – |
2022-07-26 |
4 |
S |
$43.20 |
$852,461 |
D/D |
(19,734) |
0 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Research & Investments |
• – – |
2022-07-25 |
4 |
S |
$43.05 |
$154,985 |
D/D |
(3,600) |
19,734 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Research & Investments |
• – – |
2022-06-24 |
4 |
S |
$43.19 |
$1,007,694 |
D/D |
(23,333) |
23,334 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Research & Investments |
• – – |
2022-05-16 |
4 |
S |
$39.85 |
$929,836 |
D/D |
(23,333) |
46,667 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Research & Investments |
• – – |
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
70,000 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
EVP & Co-Head of R&I |
• – – |
2021-06-07 |
4 |
S |
$47.02 |
$779,059 |
D/D |
(16,568) |
0 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP & Co-Head of R&I |
• – – |
2021-06-04 |
4 |
S |
$45.13 |
$747,662 |
D/D |
(16,566) |
16,568 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP & Co-Head Research & Inv. |
• – – |
2021-06-02 |
4 |
S |
$41.52 |
$604,850 |
D/D |
(14,566) |
33,134 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP & Co-Head Research & Inv. |
• – – |
2021-05-21 |
4 |
S |
$41.00 |
$4,100 |
D/D |
(100) |
47,700 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP & Co-Head Research & Inv. |
• – – |
2021-05-20 |
4 |
S |
$41.08 |
$78,059 |
D/D |
(1,900) |
47,800 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP & Co-Head Research & Inv. |
• – – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
49,700 |
49,700 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
EVP & Co-Head Research & Inv.O |
• – – |
2020-12-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
19,020 |
|
% |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
